Population groups | Genotype frequency (%) | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTO rs2892469 | FTO rs1861869 | FTO rs17217144 | FTO rs7186521 | TBC1D1 rs6850200 | |||||||||||||||||
CC | TT | CT | p value | CC | GG | CG | p value | CC | TT | CT | p value | AA | GG | AG | p value | AA | CC | CA | p value | ||
Second patient cohort | Greek healthy individuals | 26 | 36 | 38 | 0.005 | 21 | 41 | 38 | 0.003 | 0 | 0 | 100 | PA = 1.55e−12 PB = 7.78e−13 | 0 | 0 | 100 | 1.0 | 18 | 45 | 38 | 0.017 |
Greek sALS patients | 17 | 22 | 61 | 17 | 22 | 61 | 22 | 13 | 65 | 0 | 0 | 100 | 9 | 35 | 57 | ||||||
Third patient cohort | Greek healthy individuals | 26 | 36 | 38 | 0.033 | 21 | 41 | 38 | PA = 0.072 PB = 0.071 | 6 | 2 | 92 | 0.002 | 0 | 0 | 100 | 5.13e−39 | 14 | 43 | 43 | 0.723 |
Greek sALS patients | 21 | 23 | 56 | 17 | 29 | 54 | 22 | 2 | 76 | 18 | 65 | 18 | 11 | 42 | 48 | ||||||
Sardinian healthy individuals | 38 | 25 | 38 | 0.63 | 36 | 31 | 33 | 0.61 | 24 | 36 | 40 | 0.67 | 35 | 22 | 42 | 0.64 | 20 | 41 | 39 | 0.53 | |
Sardinian sALS patients | 31 | 28 | 41 | 29 | 34 | 37 | 27 | 30 | 43 | 29 | 25 | 46 | 15 | 39 | 46 | ||||||
Turkish healthy individuals | 26 | 26 | 49 | 0.62 | 0 | 100 | 0 | 0.49 | 26 | 26 | 49 | 0.62 | 26 | 26 | 49 | 0.09 | 18 | 45 | 38 | 0.57 | |
Turkish sALS patients | 24 | 21 | 55 | 0 | 99 | 1 | 26 | 20 | 54 | 21 | 26 | 53 | 13 | 44 | 43 |